300558.SZ

Betta Pharmaceuticals Co., Ltd. [300558.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

300558.SZ Stock Summary

In the News

300558.SZ Financial details

Company Rating
-
Market Cap
15.89B
Income
347.31M
Revenue
2.76B
Book val./share
-
Cash/share
-
Dividend
0.07
Dividend %
0.15%
Employees
1.96K
Optionable
No
Shortable
Yes
Earnings
20 Apr 2024
P/E
58.84
Forward P/E
-
PEG
-54.13
P/S
7.24
P/B
3.9
P/C
-
P/FCF
-44.83
Quick Ratio
0.79
Current Ratio
1.11
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.82
EPS next Y
-
EPS next Q
-
EPS this Y
-61.96%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.58%
Revenue last 5Y
14.19%
Revenue Q/Q
-6.72%
EPS Q/Q
60.87%
-
-
-
-
SMA20
-5.66%
SMA50
-1.96%
SMA100
-7.41%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
7%
ROC
0.03%
Gross Margin
87%
Oper. Margin
9%
Profit Margin
13%
Payout
23%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
33.11-74.83
52W High
-31.68%
52W Low
+53.21%
RSI
49
Rel Volume
0.96
Avg Volume
5.08M
Volume
4.9M
Perf Week
1.06%
Perf Month
-4.46%
Perf Quarter
5.18%
Perf Half Y
5.44%
-
-
-
-
Beta
0.708
-
-
Volatility
0.45%, 1.65%
Prev Close
0%
Price
50.56
Change
-4.02%

300558.SZ Financial Performance

300558.SZ Dividend History

300558.SZ Frequently Asked Questions

What is Betta Pharmaceuticals Co., Ltd. stock symbol ?

Betta Pharmaceuticals Co., Ltd. is a CN stock and trading under the symbol 300558.SZ

What is Betta Pharmaceuticals Co., Ltd. stock quote today ?

Betta Pharmaceuticals Co., Ltd. stock price is $50.56 today.

Is Betta Pharmaceuticals Co., Ltd. stock public?

Yes, Betta Pharmaceuticals Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
APC.DE
VFINX
ABEA.DE
META
M&M.NS
Same Sector
CSBR
3689.HK
HLYK
MKEA.PA
ARVN
Same Price Range
PTT-R.BK
LBRT.L
UEVM
NVBW
CWBK
Similar Market Cap
002281.SZ
2674.T
600521.SS
DOCU
JUEAX

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 5.08M
  • Market Capitalization 15.89B
  • Employee 1.96K
  • CEO Dr. Lieming Ding
  • Headquarters Hangzhou,CN
  • IPO Date 2016-11-09
  • Website https://www.bettapharma.com

Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China.